Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Other Working Capital Changes (2014 - 2025)

Mesoblast's (MEOBF) quarterly Other Working Capital Changes came in at -$865000.0 in Q2 2023, down 101.63% year-over-year from $53.0 million in Q2 2022, and down 26.83% quarter-over-quarter from -$682000.0 in Q1 2023.

Analysis

Mesoblast (MEOBF) Other Working Capital Changes (2014 - 2025) Analysis & Trends

Mesoblast has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$3.0 million for Q2 2025.

  • In Q2 2023, Other Working Capital Changes fell 101.63% year-over-year to -$865000.0; the TTM figure through Jun 2023 stood at -$3.1 million (down 11.94% YoY), while the FY2026 annual figure was -$2.3 million, down 18.91% from the prior year.
  • Other Working Capital Changes came in at -$865000.0 for Q2 2023 at Mesoblast, down from -$682000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of -$335000.0 in Q3 2019 to a low of -$1.2 million in Q1 2020.
  • Average Other Working Capital Changes over 5 years is -$731923.1, with a median of -$695000.0 recorded in 2019.
  • Year-over-year, Other Working Capital Changes tumbled 107.46% in 2020 and surged 49.14% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$695000.0 in 2019, then slipped by 12.95% to -$785000.0 in 2020, then jumped by 32.74% to -$528000.0 in 2021, then gained by 18.75% to -$429000.0 in 2022, then plunged by 101.63% to -$865000.0 in 2023.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$865000.0 in Q2 2023, -$682000.0 in Q1 2023, and -$429000.0 in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.02 Mn
Jun 30, 2025 -3.02 Mn
Sep 30, 2019 -164,000.00
Sep 30, 2019 -164,000.00
Sep 30, 2018 -251,000.00
Sep 30, 2018 -251,000.00
Sep 30, 2017 1.33 Mn
Sep 30, 2017 1.33 Mn
Sep 30, 2015 -227,000.00
Sep 30, 2015 -227,000.00
Sep 30, 2014 -641,000.00
Sep 30, 2014 -641,000.00